CPHRF (Cipher Pharmaceuticals) E10: $0.28 (As of Mar. 2026)


CPHRF Cipher Pharmaceuticals Inc CPHRF
96 GF Score
Price $11.43
GF Value $12.19
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals E10?

Cipher Pharmaceuticals CPHRF 96 E10 is $0.28 as of Mar. 2026. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.19 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cipher Pharmaceuticals's average E10 Growth Rate was 95.00% per year. During the past 3 years, the average E10 Growth Rate was 12.80% per year. During the past 5 years, the average E10 Growth Rate was 38.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cipher Pharmaceuticals was 97.20% per year. The lowest was 0.00% per year. And the median was 23.90% per year.

As of today (2026-06-24), Cipher Pharmaceuticals's current stock price is $11.43. Cipher Pharmaceuticals's E10 for the quarter that ended in Mar. 2026 was $0.28. Cipher Pharmaceuticals's Shiller PE Ratio of today is 40.82.

During the past 13 years, the highest Shiller PE Ratio of Cipher Pharmaceuticals was 316.00. The lowest was 13.67. And the median was 31.63.


Cipher Pharmaceuticals  (OTCPK:CPHRF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cipher Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=11.43/0.28
=40.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Cipher Pharmaceuticals was 316.00. The lowest was 13.67. And the median was 31.63.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cipher Pharmaceuticals E10 Related Terms


Cipher Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Cipher Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals E10 Chart

Cipher Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.17 0.17 0.13 0.24

Cipher Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.17 0.20 0.24 0.28

CPHRF vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Shiller PE Ratio falls into.


CPHRF
96GF Score
Cipher Pharmaceuticals Inc CPHRF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipher Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipher Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.24/132.2623*132.2623
=0.240

Current CPI (Mar. 2026) = 132.2623.

Cipher Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201606 -0.130 102.002 -0.169
201609 -0.810 101.765 -1.053
201612 -0.430 101.449 -0.561
201703 -0.130 102.634 -0.168
201706 0.040 103.029 0.051
201709 0.100 103.345 0.128
201712 0.140 103.345 0.179
201803 -0.050 105.004 -0.063
201806 0.080 105.557 0.100
201809 0.030 105.636 0.038
201812 -0.040 105.399 -0.050
201903 0.030 106.979 0.037
201906 0.050 107.690 0.061
201909 -0.080 107.611 -0.098
201912 0.110 107.769 0.135
202003 0.100 107.927 0.123
202006 0.020 108.401 0.024
202009 0.060 108.164 0.073
202012 -0.010 108.559 -0.012
202103 0.050 110.298 0.060
202106 0.100 111.720 0.118
202109 0.030 112.905 0.035
202112 0.100 113.774 0.116
202203 0.080 117.646 0.090
202206 0.080 120.806 0.088
202209 0.100 120.648 0.110
202212 0.760 120.964 0.831
202303 0.100 122.702 0.108
202306 0.120 124.203 0.128
202309 0.270 125.230 0.285
202312 0.300 125.072 0.317
202403 0.200 126.258 0.210
202406 0.120 127.522 0.124
202409 0.010 127.285 0.010
202412 0.130 127.364 0.135
202503 0.100 129.181 0.102
202506 0.220 129.892 0.224
202509 0.210 130.287 0.213
202512 0.510 130.366 0.517
202603 0.240 132.262 0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.28 mean?
Cipher Pharmaceuticals (CPHRF) has a E10 of $0.28 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cipher Pharmaceuticals and its competitors.
Is Cipher Pharmaceuticals' E10 too high?
Cipher Pharmaceuticals' current E10 is $0.28. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' E10 compare to ZTS?
Cipher Pharmaceuticals' E10 of $0.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cipher Pharmaceuticals and its competitors. Cipher Pharmaceuticals's current E10 is $0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.19, compared to a current price of $11.43 — trading 6.2% below its estimated fair value. The current E10 is $0.28. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current E10 is $0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of $11.43 is trading 6.2% below its estimated GF Value™ of $12.19. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for CPHRF:

  • E10: $0.28
  • GF Value™: $12.19 vs. price of $11.43 (6.2% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cipher Pharmaceuticals Business Description

Other Exchanges PHE:GermanyCPH:Canada
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score

Get the complete analysis for CPHRF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.43
Price
$12.19
GF Value